PepGen & United States — Food and Drug Administration
2 shared events · Importance 3 · Last updated Jul 20, 2025
Live sentiment trends, interaction importance charts, and action volume tracking available on the
NewsDesk Dashboard
Regulatory
PepGen: PepGen is being sued for allegedly issuing materially false and/or misleading statements regarding its lead product candidate, PGN-EDO51, and its CONNECT2 study, which could lead to financial losses for the company and its shareholders.
Jun 12, 2025 · 6 articles
Business
PepGen: PepGen is facing a class action lawsuit due to alleged false statements regarding the effectiveness and safety of its lead product candidate, PGN-EDO51, and the CONNECT2 study.
Jun 11, 2025 · 17 articles
NEWSDESK
Explore this relationship live
Track how PepGen and United States — Food and Drug Administration interact across events, view sentiment trends, and discover connected entities.
Open Dashboard